Tiantian Zhang

Efficacy and safety of RC48 in combination with PD-1 inhibitors for the treatment of locally advanced or metastatic urothelial carcinoma: a single-center, real-world study.

Journal: Discover oncology

Published: December 03, 2024

Dynamic variations in peripheral blood indices and their association with efficacy and adverse reactions of pd- 1 inhibitor combined chemotherapy in patients with advanced gastric cancer.

Journal: BMC gastroenterology

Published: November 05, 2024

Evaluation of the efficacy and predictive indicators of PD- 1 inhibitors combined with chemotherapy in advanced pancreatic cancer.

Journal: Scientific reports

Published: October 14, 2024

ZC3H13 promotes autophagy in bladder cancer through m6A methylation modification of PJA2 and ubiquitination of KSR1.

Journal: Human cell

Published: July 31, 2024

Evaluation of Efficacy and Safety in First-Line Treatment Methods for Extensive-Stage Small Cell Lung Cancer: A Comprehensive Comparative Study of Chemotherapy, Targeted Therapy Combined With Chemotherapy, and Immunotherapy Combined With Chemotherapy.

Journal: The clinical respiratory journal

Published: November 03, 2023

TMEM200A is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer.

Journal: PeerJ

Published: February 09, 2023

The Role of SETBP1 in Gastric Cancer: Friend or Foe.

Journal: Frontiers in oncology

Published: March 31, 2022

The tumor immune-microenvironment in gastric cancer.

Journal: Tumori

Published: February 24, 2022

HHLA2 Activates the JAK/STAT Signaling Pathway by Binding to TMIGD2 in Hepatocellular Carcinoma Cells.

Journal: Inflammation

Published: December 06, 2021

Interferon Gamma-Induced Interferon Regulatory Factor 1 Activates Transcription of HHLA2 and Induces Immune Escape of Hepatocellular Carcinoma Cells.

Journal: Inflammation

Published: May 08, 2021

Malignant Peripheral Nerve Sheath Tumor of the Cervix.

Journal: Journal of the College of Physicians and Surgeons--Pakistan : JCPSP

Efficacy and safety of RC48 in combination with PD-1 inhibitors for the treatment of locally advanced or metastatic urothelial carcinoma: a single-center, real-world study.

Efficacy and safety of RC48 in combination with PD-1 inhibitors for the treatment of locally advanced or metastatic urothelial carcinoma: a single-center, real-world study.

Dynamic variations in peripheral blood indices and their association with efficacy and adverse reactions of pd- 1 inhibitor combined chemotherapy in patients with advanced gastric cancer.

Dynamic variations in peripheral blood indices and their association with efficacy and adverse reactions of pd- 1 inhibitor combined chemotherapy in patients with advanced gastric cancer.

Evaluation of the efficacy and predictive indicators of PD- 1 inhibitors combined with chemotherapy in advanced pancreatic cancer.

Evaluation of the efficacy and predictive indicators of PD- 1 inhibitors combined with chemotherapy in advanced pancreatic cancer.

ZC3H13 promotes autophagy in bladder cancer through m6A methylation modification of PJA2 and ubiquitination of KSR1.

ZC3H13 promotes autophagy in bladder cancer through m6A methylation modification of PJA2 and ubiquitination of KSR1.

Evaluation of Efficacy and Safety in First-Line Treatment Methods for Extensive-Stage Small Cell Lung Cancer: A Comprehensive Comparative Study of Chemotherapy, Targeted Therapy Combined With Chemotherapy, and Immunotherapy Combined With Chemotherapy.

Evaluation of Efficacy and Safety in First-Line Treatment Methods for Extensive-Stage Small Cell Lung Cancer: A Comprehensive Comparative Study of Chemotherapy, Targeted Therapy Combined With Chemotherapy, and Immunotherapy Combined With Chemotherapy.

TMEM200A is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer.

TMEM200A is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer.

The Role of SETBP1 in Gastric Cancer: Friend or Foe.

The Role of SETBP1 in Gastric Cancer: Friend or Foe.

The tumor immune-microenvironment in gastric cancer.

The tumor immune-microenvironment in gastric cancer.

HHLA2 Activates the JAK/STAT Signaling Pathway by Binding to TMIGD2 in Hepatocellular Carcinoma Cells.

HHLA2 Activates the JAK/STAT Signaling Pathway by Binding to TMIGD2 in Hepatocellular Carcinoma Cells.

Interferon Gamma-Induced Interferon Regulatory Factor 1 Activates Transcription of HHLA2 and Induces Immune Escape of Hepatocellular Carcinoma Cells.

Interferon Gamma-Induced Interferon Regulatory Factor 1 Activates Transcription of HHLA2 and Induces Immune Escape of Hepatocellular Carcinoma Cells.

Malignant Peripheral Nerve Sheath Tumor of the Cervix.

Malignant Peripheral Nerve Sheath Tumor of the Cervix.

Lung cancer with dermatomyositis as the initial diagnosis: A case report.

Lung cancer with dermatomyositis as the initial diagnosis: A case report.